Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Cheers! Kind of hoping for a Nasdaq listing. Will be valued far better for shareholders I feel.
Thank you Calum for the link . :)
Yep..Cathal did say that they have been given the green light monetise Imutex.
He's said in previous interviews that they are on the same page with regards to immutex
I think CF has been kissing the Blarney stone a bit to much lately. As for Immutex it not in his control as a minority partner to SEEK Group who own 51%of the JV..I think Geoff Stoloff still controls the destiny of Immutex...CF should just concentrate on the things he took the company on board to do, that is to be service provider to pharmaceutical companies...the picture is getting too confused by Immutex and Covid 19..
There has been no communication from Arcacia apparently, so they didn't give the company an opportunity to place them.. really no big deal, be gone soon
The more hope CF gives, the worst the SP performs....this will be another wait and (let's) see AIM story.
I agree Bronx....it appears strange that CF says the offer was 5x oversubscribed with II's queuing up for shares..now they can't even soak up a few % from Acacia sale..? It's a mystery...
Topped with another £1200, that's me done at £6200. GLA!!!!!! Hope next week is fruitful
Thanks Demon. I'm relatively new to trading, have held shares as an investment for a while. The strategy that has worked best for me is to buy shares that make new yearly or all time highs that's how Orph came up on a my radar. I'm quite strict with my stop losses now, max 10% so I've stopped out on a few, some which has proved right some not, made a mess of both ODX and GENE, where good money was to be made trading. I do not average down like a lot do, if anything I will average up. I have bought in twice here and made money and once where I got stopped out. Now I'm in for a 4th time and my notes say I have targetted yearly high around 16p. So I have a stop @ 10.9, 6% loss but an upside of 16p which is a 38% profit, a nice risk reward play, but that was when the share had a lot more momemtum. It has gone flat, so I'll see what happens.
Good to hear a different POV Repression. I get it, if you can get 10-20% on each stock you invest in, it doesn't take long before you build a very nice portfolio. 10% here takes us to circa 12.8 though, which is a huge buy signal if I'm not mistaken. I'm not a huge chartist but I believe (from a chart perspective) once this is breached there is no holding it back until it hits 16 which is circa 33 % increase on current SP. Previous high was 16.5ish and this was before the last two RNS updates which have added zero value due to the Acacia sell-off. So as much as I respect your strategy, there are times when you need to take a step back and look at the full picture, rather than simple binary numbers. I get it though, I know from experience that you just don't know what's round the corner, nothing is guaranteed in life. Different strokes and all that. GLA
I have, I've told you my reason for buying and the how I see it the simple risk/reward. I'm not here to fall in love with the company, just to make 10-20% and I'm out, or if the news/hype comes I might ride it longer. I look at loads of companies and I do like the set up of this one on the charts. It's not like everything is pointing downwards - like some people buy into.
Repression I suggest you do Due Diligence rather than wasting our time..
This is where my recent buy was _ 11.50. Bought purely because I thought it was a good risk/reward play here. If it drops below the placing/20 day ema I'm out for a small loss, but hopefully news will come and it will move up - or hype/ramping will return and bring the lemmings. It's only been a month since I bought but think it seems a lot longer as nothing has happened in that time where as before there was frequent news and a lot of activity. Traded it a couple of times and made good money on the way up. Not sure what the company does really. Cathal seems a bit of a smoothie. Be interested to hear how gullible types view him?
And I hate saying this as it's tempting Providence, and aim as we know does what it wants but it feels like there is a pretty solid floor at 11 to 11.5p....
He spoke about this on a previous interview and feels the overhang will clear soon and be able to start moving up again..
Sounds rampy but it is an opportunity to build a holding at this level..
Bit miffed that the institutions that Cathal had lined up in the capital raise aren't overpowering this seller..
Btw listened to the interview..who are the other company doing antiviral testing?We only know of the Russian 1.
I have added more to my holding after listening to this interview. Delighted and could easily make my money back when Immutex is sold or listed on NASDAQ. It was a no brainer for me.
That makes me want to buy more but I've sold all my FTSE 100 stock now... Mmmm
Thanks ccalum07
CF sounds v positive and a good to here a bit more on IMUTEX!
https://soundcloud.com/doc-h-4/orph-interview-with-cathal?ref=twitter